Related references
Note: Only part of the references are listed.MONITORING THE SOLUBLE AMYLOID PRECURSOR PROTEIN ALPHA (SAPPA) AND BETA (SAPPB) FRAGMENTS IN PLASMA AND CSF FROM HEALTHY INDIVIDUALS TREATED WITH BACE INHIBITOR AZD3293 IN A MULTIPLE ASCENDING DOSE STUDY: PHARMACOKINETIC AND PHARMACODYNAMIC CORRELATE
Kina Höglund et al.
Alzheimers & Dementia (2014)
Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein
Janice A. Maloney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Alzheimer Disease Protective Mutation A2T Modulates Kinetic and Thermodynamic Properties of Amyloid-β (Aβ) Aggregation
Iryna Benilova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
AZD3293 A NOVEL BACE1 INHIBITOR: SAFETY, TOLERABILITY, AND EFFECTS ON PLASMA AND CSF Aβ PEPTIDES FOLLOWING SINGLE- AND MULTIPLE-DOSE ADMINISTRATION
Robert Alexander et al.
NEUROBIOLOGY OF AGING (2014)
Genetic Inhibition of Phosphorylation of the Translation Initiation Factor eIF2α Does Not Block Aβ-Dependent Elevation of BACE1 and APP Levels or Reduce Amyloid Pathology in a Mouse Model of Alzheimer's Disease
Katherine R. Sadleir et al.
PLOS ONE (2014)
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
Y. Joy Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The Alzheimer's β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques
Patty C. Kandalepas et al.
ACTA NEUROPATHOLOGICA (2013)
The novel BACE inhibitor MK-8931 dramatically lowers CSF beta-amyloid in patients with mild-to-moderate Alzheimer's disease
Mark Forman et al.
Alzheimers & Dementia (2013)
Clinical study of E2609, a novel BACE1 inhibitor, demonstrates target engagement and inhibition of BACE1 activity in CSF
Francois Bernier et al.
Alzheimers & Dementia (2013)
Allosteric inhibition of BACE1 by an exosite-binding antibody
Weiru Wang et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2013)
Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles
Cyril Cheret et al.
EMBO JOURNAL (2013)
Increased Expression of Reticulon 3 in Neurons Leads to Reduced Axonal Transport of β Site Amyloid Precursor Protein-cleaving Enzyme 1
Minzi Deng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Dual Cleavage of Neuregulin 1 Type III by BACE1 and ADAM17 Liberates Its EGF-Like Domain and Allows Paracrine Signaling
Daniel Fleck et al.
JOURNAL OF NEUROSCIENCE (2013)
Immunotherapy for Alzheimer's disease: hoops and hurdles
Cynthia A. Lemere
MOLECULAR NEURODEGENERATION (2013)
Current concepts in Alzheimer's Disease: molecules, models and translational perspectives
Bart P. F. Rutten et al.
MOLECULAR NEURODEGENERATION (2013)
Fluid biomarkers in Alzheimer's disease - current concepts
Christoffer Rosen et al.
MOLECULAR NEURODEGENERATION (2013)
Cross-talk of membrane lipids and Alzheimer-related proteins
Jochen Walter et al.
MOLECULAR NEURODEGENERATION (2013)
Blood-brain-barriers in aging and in Alzheimer's disease
Fernanda Marques et al.
MOLECULAR NEURODEGENERATION (2013)
Biomarker Modeling of Alzheimer's Disease
Clifford R. Jack et al.
NEURON (2013)
Genetic and biochemical evidence for a functional role of BACE1 in the regulation of insulin mRNA expression
Albrecht Hoffmeister et al.
OBESITY (2013)
BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells
Leila Rochin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
BACE1 Regulates Hippocampal Astrogenesis via the Jagged1-Notch Pathway
Xiangyou Hu et al.
CELL REPORTS (2013)
The novel BACE inhibitor MK-8931 dramatically lowers cerebrospinal fluid Aβ peptides in healthy subjects following single- and multiple-dose administration
Mark Forman et al.
Alzheimers & Dementia (2012)
Central BACE1 inhibition by LY2886721 produces opposing effects on APP processing as reflected by cerebrospinal fluid sAPPalpha and sAPPbeta
Brian Willis et al.
Alzheimers & Dementia (2012)
BACE inhibitor LY2886721 safety and central and peripheral PK and PD in healthy subjects (HSs)
Ferenc Martenyi et al.
Alzheimers & Dementia (2012)
First-in-human study of E2609, a novel BACE1 inhibitor, demonstrates prolonged reductions in plasma beta-amyloid levels after single dosing
Robert Lai et al.
Alzheimers & Dementia (2012)
Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice
Paul J. Meakin et al.
BIOCHEMICAL JOURNAL (2012)
Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement
Erik S. Musiek et al.
CURRENT OPINION IN NEUROLOGY (2012)
Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons
Peer-Hendrik Kuhn et al.
EMBO JOURNAL (2012)
ß-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment
Jun Cai et al.
EMBO MOLECULAR MEDICINE (2012)
Small-molecule BACE1 inhibitors: a patent literature review (2006-2011)
Gary Probst et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Cdk5 Protein Inhibition and Aβ42 Increase BACE1 Protein Level in Primary Neurons by a Post-transcriptional Mechanism IMPLICATIONS OF CDK5 AS A THERAPEUTIC TARGET FOR ALZHEIMER DISEASE
Katherine R. Sadleir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
β-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects
Brian Hitt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Neural Cell Adhesion Molecules L1 and CHL1 Are Cleaved by BACE1 Protease in Vivo
Lujia Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Axonal regulation of Schwann cell ensheathment and myelination
James L. Salzer
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2012)
Sorting nexin 12 interacts with BACE1 and regulates BACE1-mediated APP processing
Yonghao Zhao et al.
MOLECULAR NEURODEGENERATION (2012)
Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP/PS1 hippocampus
Manuel Torres et al.
Molecular Neurodegeneration (2012)
Identification of BACE2 as an avid β-amyloid-degrading protease
Samer O. Abdul-Hay et al.
MOLECULAR NEURODEGENERATION (2012)
BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's disease
Linda Chami et al.
MOLECULAR NEURODEGENERATION (2012)
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline
Thorlakur Jonsson et al.
NATURE (2012)
Beneficial Effect of Antibodies against β- Secretase Cleavage Site of App on Alzheimer's-Like Pathology in Triple-Transgenic Mice
Inna Rabinovich-Nikitin et al.
PLOS ONE (2012)
Alzheimer Disease: New Concepts on Its Neurobiology and the Clinical Role Imaging Will Play
Clifford R. Jack
RADIOLOGY (2012)
The Genetics of Alzheimer Disease
Rudolph E. Tanzi
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment
Rawan Tarawneh et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass
Daria Esterhazy et al.
CELL METABOLISM (2011)
Inhibition of β-Secretase in Vivo via Antibody Binding to Unique Loops (D and F) of BACE1
Lujia Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cleavage of Neuregulin-1 by BACE1 or ADAM10 Protein Produces Differential Effects on Myelination
Xiaoyang Luo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Inhibiting β-Secretase Activity in Alzheimer's Disease Cell Models with Single-Chain Antibodies Specifically Targeting APP
Shanta Boddapati et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor
Patrick C. May et al.
JOURNAL OF NEUROSCIENCE (2011)
The Alzheimer's β-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb
Tharinda W. Rajapaksha et al.
MOLECULAR NEURODEGENERATION (2011)
A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo
Jasvinder K. Atwal et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration
Xiangyou Hu et al.
JOURNAL OF NEUROSCIENCE (2010)
BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization
Brian D. Hitt et al.
MOLECULAR NEURODEGENERATION (2010)
The secretases: enzymes with therapeutic potential in Alzheimer disease
Bart De Strooper et al.
NATURE REVIEWS NEUROLOGY (2010)
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Raphael Kopan et al.
CELL (2009)
beta-Secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development
Xue-Mei Zhang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential
Robert Vassar et al.
JOURNAL OF NEUROSCIENCE (2009)
A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis
Giuseppe Di Fede et al.
SCIENCE (2009)
Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves
Xiangyou Hu et al.
FASEB JOURNAL (2008)
BACE1 gene deletion:: Impact on behavioral function in a model of Alzheimer's disease
Dione Kobayashi et al.
NEUROBIOLOGY OF AGING (2008)
Abnormal axonal guidance and brain anatomy in mouse mutants for the cell recognition molecules close homolog of L1 and NgCAM-related cell adhesion molecule
A. Heyden et al.
NEUROSCIENCE (2008)
Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice
A. V. Savonenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice
Lisa McConlogue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
BACE1 regulates voltage-gated sodium channels and neuronal activity
Doo Yeon Kim et al.
NATURE CELL BIOLOGY (2007)
Hypoxia-inducible factor 1α (HIF-1α)-mediated hypoxia increases BACE1 expression and β-amyloid generation
Xian Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
β-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques:: Implications for Alzheimer's disease pathogenesis
Jie Zhao et al.
JOURNAL OF NEUROSCIENCE (2007)
BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice
Masuo Ohno et al.
NEUROBIOLOGY OF DISEASE (2007)
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
Xiulian Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Bace1 modulates myelination in the central and peripheral nervous system
Xiangyou Hu et al.
NATURE NEUROSCIENCE (2006)
Control of peripheral nerve myelination by the β-secretase BACE1
Michael Willem et al.
SCIENCE (2006)
Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1
M Ohno et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Transcriptional and translational regulation of BACE1 expression - Implications for Alzheimer's disease
Steffen Rossner et al.
PROGRESS IN NEUROBIOLOGY (2006)
BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions
FM Laird et al.
JOURNAL OF NEUROSCIENCE (2005)
Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice
D Dominguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of amyloid precursor protein processing by β-secretase through site-directed antibodies
M Arbel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients
R Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease
M Ohno et al.
NEURON (2004)
BACE1 (β-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time
Y Luo et al.
NEUROBIOLOGY OF DISEASE (2003)
Antagonistic effects of β-site amyloid precursor protein-cleaving enzymes 1 and 2 on β-amyloid peptide production in cells
G Basi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
LB Yang et al.
NATURE MEDICINE (2003)
BACE1 (beta-secretase) transgenic neurochernical deficits ind knockout mice: identification of and behavioral changes
SM Harrison et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2003)
Misguided axonal projections, neural cell adhesion molecule 180 mRNA upregulation, and altered behavior in mice deficient for the close homolog of L1
M Montag-Sallaz et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Crystal structure of memapsin 2 (β-secretase) in complex with an inhibitor OM00-3
L Hong et al.
BIOCHEMISTRY (2002)
β-secretase protein and activity are increased in the neocortex in Alzheimer disease
H Fukumoto et al.
ARCHIVES OF NEUROLOGY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Increased expression of the amyloid precursor β-secretase in Alzheimer's disease
RMD Holsinger et al.
ANNALS OF NEUROLOGY (2002)
A non-amyloidogenic function of BACE-2 in the secretory pathway
R Fluhrer et al.
JOURNAL OF NEUROCHEMISTRY (2002)
γ-Secretase, notch, Aβ and Alzheimer's disease:: Where do the presenilins fit in?
SS Sisodia et al.
NATURE REVIEWS NEUROSCIENCE (2002)
BACE2 functions as an alternative α-secretase in cells
RQ Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain:: implications for Alzheimer's disease therapeutics
SL Roberds et al.
HUMAN MOLECULAR GENETICS (2001)
Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation
Y Luo et al.
NATURE NEUROSCIENCE (2001)
BACE1 is the major β-secretase for generation of Aβ peptides by neurons
HB Cai et al.
NATURE NEUROSCIENCE (2001)
Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor
L Hong et al.
SCIENCE (2000)
BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein
M Farzan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Expression analysis of BACE2 in brain and peripheral tissues
BD Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein
XL Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein beta-secretase
A Solans et al.
CYTOGENETICS AND CELL GENETICS (2000)
Share Paper
